Drugs / Provisc
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT01912638 Comparator | Jul 2012 → Sep 2016 | steroid-induced glaucoma | National Centre of Ophthalmology named after academician Zarifa Aliyeva | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Provisc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01912638 ↗ |
| Modality | Other / unclassified | “Provisc is an cohesive viscoelastic.” NCT01912638 ↗ |
| Route | Other | “cohesive viscoelastic (Provisc) is injected under the scleral flap to prevent early hypotony.” NCT01912638 ↗ |